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Public Health Research Priorities to Address
Female Genital Mutilation or Cutting in the United
States
Female genital mutilation or cut-
ting (FGM/C), an age-old tradition
that is still widely practiced around
the world, is gaining recognition
asan importantpublichealth issue
in the United States. Increasingly,
because ofmigration,women and
girls affected by FGM/C have be-
come members of host commu-
nities where the practice is not
culturally acceptable.
According to recent conserva-
tive estimates,more than513000
immigrant women and girls living
in the United States have un-
dergoneor are at risk for FGM/C, a
significant increase from the 1990
estimate of 168 000. The arrests
of physicians in Michigan in 2017
for performing FGM/C on minors
underscores the fact that cutting
is happening in the United States.
We have identified numerous
gaps in our understanding of the
magnitude of the problem in the
United States and in the avail-
ability of scientific data informing
a variety of interventions (pre-
ventive, clinical, educational, le-
gal).We catalog thesemajor gaps
and propose a research agenda
that can help public health ex-
perts, researchers, clinicians, and
other stakeholders to establish
priorities as we confront FGM/C as
an important health issue affecting
hundreds of thousands of women
and girls in the United States. (Am J
Public Health. 2019;109:1523–1527.
doi:10.2105/AJPH.2019.305259)
Holly G. Atkinson, MD, FACP, Deborah Ottenheimer, MD, FACOG, and Ranit Mishori, MD, MHS,
FAAFP
The World Health Organi-zation (WHO) has defined
female genital mutilation or
cutting (FGM/C) as “all pro-
cedures that involve partial or
total removal of the external fe-
male genitalia, or other injury to
the female genital organs, for
non-medical reasons,” and has
classified FGM/C into four
fundamental types (with several
subclassifications added in 2016.)1
FGM/C is practiced around the
world, primarily in Africa (e.g.,
Somalia, Guinea), the Middle
East (e.g., Iraq, Yemen) and
Southeast Asia (e.g., Indonesia).2
Increasingly, because of migra-
tion, women and girls affected by
FGM/C have become members
of societies where the practice is
not normative, including the
United States.
In October 2018, a federal
judge in Michigan ruled that the
1996 US federal law banning
FGM/C is unconstitutional, and
dismissed key charges against two
physicians accused of performing
FGM/C on upwards of 100 girls
from several states.3 The ruling
has rattled survivors and anti-
FGM/C advocates, putting the
legal battle to ban FGM/C, even
in the US context, front and
center. Past media reports have
publicized the arrests of parents
in the United States who have
undertaken the cutting of their
daughters’ genitalia.4 There have
also been reports of traditional
cutters performing FGM/C on
girls living in America.5 In part
because of the media coverage of
these cases, as well as outreach
efforts by the US Department of
Justice following the Michigan
case, the medical community has
become increasingly aware of the
knowledge gaps and complex
issues facing health care providers
with respect to FGM/C. This has
led to an enhanced interest in
exploring the evidence regarding
prevention of the practice, man-
agement of its consequences, and
culturally appropriate support
of affected women and girls.
In collaboration with col-
leagues, we have identified
numerous gaps in our under-
standing of the magnitude of
the problem in the United States
and in the availability of data
informing a variety of interven-
tions (clinical, educational, legal,
etc.). In this commentary, we
catalog these major gaps and pro-
pose a research agenda that can
help establish priorities as we
confront FGM/C as a public
health issue in the United States.
Our research agenda (see the box
on page 1524) is informed by a
narrative review of the literature, a
consideration of WHO priorities,
and a synthesis of the conclusions
of the US Network to End
FGM/C: Health Care Working
Groupat theEndViolenceAgainst
Girls: Summit on FGM/C in
December 2016.
RESEARCH PRIORITIES
We have identified seven re-
search priorities.
Prevalence and Incidence
Although the exact number of
girls and women globally who
have experienced FGM/C re-
mains unknown, more than 200
million girls and women in 30
countries are estimated to have
undergone FGM/C, on the
basis of data from countrywide
surveys.2,6 In some practicing
countries FGM/C is widespread,
affecting the vast majority of the
female population, whereas in
other countries FGM/C is prac-
ticed only among subpopula-
tions, affecting a far smaller
percentage of women and girls.2
A challenge to addressing
FGM/C in the United States is
the absence of an accurate count
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of women and girls already af-
fected or at risk.The latest estimate,
from 2012, is that approximately
513 000 women and girls in the
United States had either already
undergone FGM/C or were at
risk for being cut, a substantial
upward readjustment of the 2000
estimate of 228 000.7 This half-
million estimate is imprecise for
several reasons: it uses country-
specific, national prevalence statis-
tics and applies them to a unique
segment of a country’s pop-
ulation: migrants living in the
United States. It also conflates
women and girls who may have
already been cut with girls who
were born to women from
FGM/C-practicing countries and
may be at risk of being cut.
Further, the estimate only in-
cludes immigrants from practicing
African nations and Yemen, as
only those countries’ data were
then available. It does not include
the high prevalence of FGM/C in
other countries that have been
subsequently documented (e.g.,
Indonesia).2 There is a pressing
need to collect accurate data on
the prevalence ofwomen and girls
living in the United States who
have already been cut, as well as
the incidenceof the cuttingof girls
from FGM/C-practicing groups
living in the United States, in
order to promulgate policies and
evaluate practices. We also need
to understand the age at which
FGM/C is performed on girls
living in the United States, as well
as how often it is performed here
in America versus in the family’s
country of origin during visits
abroad (“vacation cutting”), who
is doing the cutting, how it is
being carried out, and the types




Education of medical providers
about accurate identification of
FGM/C type and appropriate
International Classification of Dis-
eases, 10th Revision coding is
critical for the documentation
of prevalence and incidence in
the United States. The accurate
identification of FGM/C would
be greatly facilitated by the de-
velopment of a visual “atlas,”—
that is, a clinical visual guide.
Several basic atlases exist, themost
recent of which was published
in 20168; however, a more com-
prehensive atlas would be bene-
ficial. The appearance of scarring
due to FGM/C varies dramati-
cally with age and parity, making
visual guidance invaluable in the
assessment of affected patients. In
addition, there are currently no
visual aids for the assessment of
FGM/C in the pediatric patient.
Recognition of FGM/C is diffi-
cult but crucial in this population,
both to provide medical guidance
to girls who have been cut and to
identify at-risk siblings.
Currently, there are no vali-
dated screening tools available to
American clinicians. Although
screening tools are available in
other countries,9 including the
widely used British Safeguarding
andRiskAssessment tool10 (which
assesses the risk of girls undergoing
cutting and the medical conse-
quences of FGM/C in girls and
women), they may not be directly
applicable to the United States
given the differences in the health,
social service, and legal systems.
Research is needed to determine
the most appropriate, culturally
sensitive means of screening, as
well as the overall costs and ben-
efits of screening women and girls
from high-prevalence countries
currently residing in the United
States. In addition, development
of a validated screening tool with
which to identify at-risk girls in
pediatric settings is vital to pre-
venting FGM/C from occurring
in the United States or through
vacation cutting.
Clinical Management
There are few evidence-
based, comprehensive clinical
management guidelines for the
care of women and girls who
have been subjected to FGM/C.
The American College of Ob-
stetricians and Gynecologists
published an educational re-
source on FGM/C in 2008;
however, it has not been revised
since then.11 Extensive pro-
fessional guidance has been
PROPOSED RESEARCH PRIORITIES FOR FEMALE GENITAL MUTILATION OR CUTTING
1. Prevalence and incidence: determine the prevalence and incidence of FGM/C in the United States with greater precision and determine the demographics of affected girls
and women and at-risk girls.
2. Identification and screening: determine best practices to educate health care providers on accurate identification and documentation of FGM/C types and validate screening
tools to identify at-risk girls.
3. Clinical management: identify best practices, assess their outcomes in this population, and develop best practice guidelines for clinical management of a range of FGM/C
issues and complications, including obstetrical issues, gynecological and urological problems, sexual functioning, chronic pain and mental health issues; validate clinical
assessment tools; evaluate outcomes of surgical interventions.
4.Workforce education: identify gaps in health providers’ knowledge, attitudes, and practices; develop and validate educational tools and best practices to train the workforce
across all specialties and training levels.
5. Legal issues: determine the effectiveness of enforcement of federal and state laws on the practice of FGM/C, with particular attention to the consequences of mandatory
reporting laws on physicians, immigrant communities, parents, and at-risk or cut girls.
6. Ethical issues: determine the pressing ethical, moral, legal, and cultural conflicts facing physicians, families, and patients and incorporate into nuanced practice
recommendations.
7: Eradication and prevention strategies: systematically evaluate eradication programs’ outcomes data and determine best practices for the eradication and prevention of
FGM/C in the US context.
Note. FGM/C= female genital mutilation or cutting.
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developed in the United King-
dom9; however, the applicability
of these recommendations in the
United States has yet to be de-
termined. Most of the interna-
tional expert recommendations
address obstetrical care, specifi-
cally regarding the timing and
technique for deinfibulation.
However, consensus is lacking
with respect to the optimal tim-
ing and best surgical technique.
Researchers need to conduct
US-specific obstetric outcomes
studies investigating deinfib-
ulation timing and technique,
delivery techniques and com-
plications, and morbidity and
mortality among mothers and
newborns.
There has been little attention
paid to developing management
recommendations or systematic
guidelines for addressing gyne-
cological and urological pathol-
ogy and pelvic pain among
affected women, although these
are widely recognized compli-
cations of FGM/C.1 Additional
areas suffering from a lack of
systematic, comprehensive eval-
uation of outcomes include sex-
ual health and function, clitoral
reconstruction, and self-image
related to genital alterations.
Further, the importance of de-
veloping nonsurgical techniques,
including physical therapy, for
treating sexual dysfunction
among women with FGM/C
cannot be overemphasized.
Finally, evidence-based best
practices for addressing the
mental health needs of women
and girls living with FGM/C
have yet to be elucidated. There
is evidence that many FGM/C-
affected women suffer high
burdens of anxiety, depression, or
posttraumatic stress disorder.12
This is in addition to the psy-
chological consequences among
those who suffer from FGM/C-
associated sexual dysfunction.13
WHO currently recommends
cognitive behavioral therapy as
the preferred therapeutic mo-
dality1; however, a systematic
evaluation of a variety of psy-
chological interventions for af-
fectedwomen and girls is needed.
Workforce Education
Women and girls affected by
FGM/C invariably engage with
a variety of practitioners in the
health care sector, whether
during routine well-woman–
well-child visits, primary care
encounters, and pre-, peri-, and
postpartum appointments, or
as part of the management of
chronic and acute health issues
related to FGM/C. Yet our
literature review reveals that
American medical practitioners
are not sufficiently prepared to
care for affected women and
girls.14 There is a need for the
development of FGM/C-related
educational competencies, im-
proved training, better assess-
ments of clinicians’ knowledge
and proficiencies, evaluations of
attitudes and practices, appraisals
of communication skills, and the
creation and validation of stan-
dardized questionnaires and
assessment tools.
Workforce training has been
studied sporadically in other host
countries, in different specialties,
and at various levels of education.
Multiple published reports ad-
dress the readiness (or lack
thereof) of host countries’ health
sectors, and their ability to suc-
cessfully and appropriately man-
age those affected by FGM/C.
Small studies have assessed the
knowledge, attitudes, and prac-
tice of practitioners of various
disciplines, including nurses,
midwives, and physicians, and
from multiple specialties.15
Studies also have assessed the
knowledge, attitudes, and prac-
tice of learners at all levels of
health professional education and
show a substantial need and desire
for improved training at all levels
of practice and among different
specialties, including obstetrics
and gynecology.16,17
Ultimately, research into ed-
ucational interventions regarding
FGM/C should aim to produce
robust curricula for US health
professionals at all levels of edu-
cation, identify educational best
practices, and disseminate high-
quality training programs for
multiple specialties. Women and
girls with FGM/C seek care from
a number of different specialists,
including not only obstetrician–
gynecologists and midwives but
also pediatricians, family phy-
sicians, nurse practitioners, phy-
sician’s assistants, emergency
medicine physicians, dermatolo-
gists, plastic surgeons, and urol-




FGM/C is considered a uni-
versal human rights violation.1
In 1996, Congress passed the
Federal Prohibition of Female
Genital Mutilation Act, which
made it illegal to perform FGM/C
in the United States on anyone
younger than 18 years.18 In 2013,
the federal law was amended
to include a provision banning
vacation cutting, which prohi-
bits knowingly transporting or
attempting to send a girl younger
than 18 years outside the United
States to undergo FGM/C. The
federal law was recently declared
unconstitutional by a Michigan
federal judge; as of this writing,
several attempts at both state and
congressional levels are under
way to address this decision.19 This
resultant period of uncertainty will
no doubt serve to further confuse
many who work with FGM/C-
affected populations. Anecdotal
evidence from expert meetings
and a study of obstetrician–
gynecologists by Moaddab et al.
suggest that many US health care




With the challenge to the
federal law, individual state laws
are bound to become critical in
efforts to outlaw and curb this
practice. To date, 35 states
have specific laws prohibiting
FGM/C,20 including seven states
that explicitly ban vacation cut-
ting. State laws, however, differ
with regard to the age at which
the FGM/C prohibition applies,
the individuals who are subject
to prosecution, the penalties
for performing FGM/C, and
whether religion or culture
can be used as a defense of the
practice. Some states, moreover,
establish explicit mandatory
reporting duties for health care
providers and other professionals.
In all 50 states, child abuse statutes
define either “physical abuse” or
“sexual abuse” in such a manner
that they arguably encompass
FGM/C. As a result, health care
providers—as mandated re-
porters of child abuse—have a
duty to report cases of FGM/C
among patients younger than 18
years to the authorities.
The existence of FGM/C
laws does not necessarily mean
that they are implemented or
enforced. There is little to no
information about the effectiveness
of enforcement of state FGM/C
laws on immigrant populations,
or about how criminalization
affects trends regarding FGM/C
acceptance and practice. Many
experts believe that law en-
forcement should go hand in
hand with culturally sensitive
approaches to educating prac-
ticing migrant communities,
as well as educating those in
law enforcement who may
come in contact with them.
AJPH PERSPECTIVES
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Cross-sectoral medical and legal
collaboration is required to assess
some critical interdisciplinary is-
sues, including the following:
What will be the consequences
of overturning the federal law?
What are the effects or un-
intended consequences of man-
datory reporting laws? What are
the effects of the criminalization
of FGM/C on parents’ behaviors
and patients’ disclosures and on
immigrant communities’ atti-
tudes and behaviors? What are
the effects on children if they are
removed from their parents be-
cause they were cut?
Ethical Issues
Health care providers’ be-
havior and decision-making in
the clinical setting are shaped by a
variety of issues, including pro-
fessional guidelines, legal obli-
gations, personal morals, cultural
biases, and medical ethics. Cli-
nicians can face a number of
conflicts regarding medical,
moral, ethical, and legal obliga-
tions surrounding professional
duty, obligations to the patient,
respect for autonomy and cul-
ture, human rights, and regard for
laws, regulations, and policies.
Clinical recommendations
about FGM/C rarely address the
interplay of these complex issues.
For example, there is ambiguity
surrounding reinfibulation in a
consenting adult woman.21 Man-
datory reporting requirements
can present physicians with ethi-
cally fraught situations related to
dual loyalties—for example, sup-
porting well-meaning parents and
preserving an intact family versus
upholding the demands of the
state and potentially causing the
removal of a child from a loving
family. Suspicions regarding the
risk of vacation cutting in partic-
ular raise ethical dilemmas.22
Other dilemmas include consid-
eration of “ritual nicks” as a
compromise type of FGM/C23
and the ethical difference between
FGM/C and cosmetic labia-
plasty,24 as well as the medical-
ization of FGM/C as a means of
harm reduction.25,26 Clinical
guidelines should incorporate the




FGM/C is a complex phe-
nomenon and has different sig-
nificance and meaning among
the various cultural and ethnic
groups who practice it. Years of
international efforts to elimi-
nate FGM/C have resulted in
a significant decline in overall
prevalence in some countries;
however, it remains a pervasive
practice in others, and evidence-
based prevention and intervention
strategies that are culturally and
religiously sensitive remain a
public health priority.27 Pre-
vention and eradication in the
United States is complicated by
the mixing of multiple practicing
ethnic groups who differ in lan-
guage, culture, and traditions. To
formulate effective strategies, it is
essential to systematically evalu-
ate outcomes data of FGM/C
eradication programs, both in the
United States and abroad. Erad-
ication and prevention of FGM/C
will ultimately occur at the
intersection of public education,
professional advocacy, policy
enactment, judicial action, and
community engagement.
CONCLUSIONS
FGM/C is gaining recognition
as an important public health issue
in the United States. With rapid
growth in the numbers of immi-
grants from FGM/C-practicing
countries living in America, health
care providers will invariably
encounter women and girls who
have undergone or are at risk for
cutting. There is an urgent need
to undertake a comprehensive re-
search agenda to address the major
gaps in knowledge and establish
more rigorous evidence-based in-
terventions to address FGM/C’s
manifestations and complications,
as well as to deliver compassionate,
culturally sensitive care to the
hundreds of thousands of affected
women and girls residing in the
United States.
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